Loading...

VRTX VERTEX PHARMACEUTICALS INC Management Changes 8-K Filing

VRTX

VRTX

VERTEX PHARMACEUTICALS INC

(VRTX)

2026 8-K

Board Elections Held

Financial Results Update

Board Member Departure

FDA Application Submitted

Financial Results Report

Financial Results Report

Financial Statements

Impairment Charge

Management Changes

Financial Results

Lease Extension

Financial Results Announcement

Annual Meeting Voting Results

Financial Results

Merger Agreement

Financial Results Announcement

FDA Approval and Pricing An...

Appointment of Nancy Thornb...

Financial Results

Appointment of Director

Financial Results

Annual Meeting Voting Results

Financial Results Announcement

External Links:

On May 13, 2026, Vertex Pharmaceuticals' shareholders approved the 2026 Stock and Option Plan and elected new board members with significant support, alongside appointing Ernst & Young as their accounting firm for 2026. The 2026 plan replaces the previous 2013 plan and requires shareholder backing as indicated by favorable votes from the annual meeting.

AI Assistant

VERTEX PHARMACEUTICALS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.